DPIIT recognised startup Government of India
Startup India
Cerys Pharmaceuticals Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.7 Cr
▲ 24% YoY
Net loss · FY 2025
₹62.15 Lakh
Net margin -36.5%
EBITDA · FY 2025
-₹59.15 Lakh
EBITDA margin -34.7%
Authorised capital
₹35 Lakh
Registered with MCA
Paid-up capital
₹33 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Employees · EPFO
24
Provident fund records
Directors on board
5
As per MCA filings
About Cerys Pharmaceuticals Private Limited
Data last updated:
Cerys Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 June 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2020PTC340993. Its GSTIN is 27AAICC7719H1ZE (Maharashtra). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹35 Lakh and a paid-up capital of ₹33 Lakh. It is led by directors including Vikram Bhadoriya and Devendra Tiwari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 4th Floor Grd Plot – 224 29 Bmc Tenement Mukundrao Ambedkar Road Gaikawad Nagar, Mumbai, Maharashtra, India – 400022.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.7 Cr, a growth of 24% compared to the previous year. For the same year it recorded a net loss of ₹62.15 Lakh (net margin -36.5%) and EBITDA of -₹59.15 Lakh (EBITDA margin -34.7%). Revenue has grown at a compounded annual rate (CAGR) of 38% over three years.
The company has about 24 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Cerys Pharmaceuticals.
Cerys Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0000005). For more details, the company can be reached via its website ceryspharma.com.
Company details
CIN U74999MH2020PTC340993
Registration Number 340993
Incorporation Date 25 June 2020
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-MH-19-0000005
Recognitions & Rankings of Cerys Pharmaceuticals
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-19-0000005
Contact details
Cerys Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its website is ceryspharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address4th Floor Grd Plot – 224 29 Bmc Tenement Mukundrao Ambedkar Road Gaikawad Nagar, Mumbai, Maharashtra, India – 400022
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Cerys Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Cerys Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Cerys Pharmaceuticals operates one associated brand: Cerys Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical products and services across therapy areas such as pediatric and nutrition. | ceryspharma.com |
Business activity
The main business activity of Cerys Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Cerys Pharmaceuticals Private Limited, buy the company report.
Financials of Cerys Pharmaceuticals Private Limited
FY 2025 filings availableCerys Pharmaceuticals Private Limited reported revenue of ₹1.7 Cr (up 24% YoY) for FY 2025.
Revenue · FY 2025
₹1.7 Cr ▲ 24%
Net loss · FY 2025
₹62.15 Lakh margin -36.5%
EBITDA · FY 2025
-₹59.15 Lakh margin -34.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 24%
3 years · compounded
▲ 38%
EBITDA CAGR growth
1 year
▲ 13%
3 years · compounded
▼ 12%
Revenue has grown at a compounded annual rate (CAGR) of 38% over three years, including 24% growth in the latest year. EBITDA rose 13% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹59.15 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹62.15 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -34.7% | ||||
| Net Profit Margin | -36.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cerys Pharmaceuticals Private Limited, buy the company report.
Board of directors of Cerys Pharmaceuticals Private Limited
Cerys Pharmaceuticals has 5 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vikram Bhadoriya | Director | 10 Feb 2022 | 4 Years 8 Months | Current |
| Devendra Tiwari Also directs: Shrigarud Developers Private Limited | Director | 24 Apr 2021 | 5 Years 6 Months | Current |
| Amit Sharma Also directs: Pinaki Coals LLP, Shrigarud Developers Private Limited | Director | 25 Jun 2020 | 6 Years 4 Months | Current |
| Anurudra Mukherjee Also directs: Pinaki Coals LLP | Director | 25 Jun 2020 | 6 Years 4 Months | Current |
| Raja Ramasamy | Director | 25 Jun 2020 | 6 Years 4 Months | Current |
Auditor
Cerys Pharmaceuticals Private Limited is audited by RAKESH MAHESHWARI & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAKESH MAHESHWARI & ASSOCIATES | FY 2023 | 008023C |
Shareholding
The shareholding of Cerys Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Cerys Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Cerys Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cerys Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Cerys Pharmaceuticals Private Limited has a workforce of 24 employees on its EPFO records as of Apr 04, 2024, across 1 active EPFO establishment.
Employee count
24
Active EPFO establishments
1
Employee growth
60%
GST
Cerys Pharmaceuticals has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAICC7719H1ZE | Maharashtra | Active | 19 Nov 2020 |
| 23AAICC7719H1ZM | Madhya Pradesh | Active | 11 Sep 2020 |
To see the full GST registrations and return filing status of Cerys Pharmaceuticals Private Limited, buy the company report.
Recent activity
Cerys Pharmaceuticals Private Limited has 5 board changes on record since 2020: 5 appointments. The latest: Vikram Bhadoriya was appointed as Director on 10 Feb 2022.
AGM
Cerys Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Cerys Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Appointed
Vikram Bhadoriya was appointed as Director.
Appointed
Devendra Tiwari was appointed as Director.
Appointed
Amit Sharma was appointed as Director.
Appointed
Anurudra Mukherjee was appointed as Director.
Appointed
Raja Ramasamy was appointed as Director.
Incorporation
25 Jun 2020
Cerys Pharmaceuticals Private Limited was registered on 25 Jun 2020 with Roc Mumbai I & aged 6 years 4 months as per MCA records.
Frequently asked questions
Cerys Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 25 June 2020 (6+ years old) and is registered under CIN U74999MH2020PTC340993.
Cerys Pharmaceuticals has 5 current directors:
- Vikram Bhadoriya - Director
- Devendra Tiwari - Director
- Amit Sharma - Director
- Anurudra Mukherjee - Director
- Raja Ramasamy - Director
The latest financial statements of Cerys Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Cerys Pharmaceuticals is 27AAICC7719H1ZE, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 23AAICC7719H1ZM (Madhya Pradesh).
The CIN (Corporate Identification Number) of Cerys Pharmaceuticals is U74999MH2020PTC340993. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cerys Pharmaceuticals was incorporated on 25 June 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
Vikram Bhadoriya was appointed as Director on 10 Feb 2022. Devendra Tiwari was appointed as Director on 24 Apr 2021. Amit Sharma was appointed as Director on 25 Jun 2020. Cerys Pharmaceuticals has 5 board changes on record in total.
Yes, Cerys Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Cerys Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-19-0000005).
Cerys Pharmaceuticals can be reached through the website ceryspharma.com. Its registered office is in Mumbai, Maharashtra, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages